RIVA-VERAPAMIL SR
LABORATOIRE RIVA INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is RIVA-VERAPAMIL SR discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that RIVA-VERAPAMIL SR 240MG has been permanently discontinued (last updated October 5, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is RIVA-VERAPAMIL SR not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Other Products
AA-VERAP
AA PHARMA INC
ISOPTIN SR
Extended-ReleaseBGP PHARMA ULC
MYLAN-VERAPAMIL SR
Extended-ReleaseMYLAN PHARMACEUTICALS ULC
VERAPAMIL HYDROCHLORIDE INJECTION USP
SANDOZ CANADA INCORPORATED
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02248082
Strength
240MG
Dosage Form
TABLET (EXTENDED-RELEASE)
Route
ORAL
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.